CREB1 and non-small cell lung carcinoma: In liver kinase B1 (LKB1) mutant non-small cell lung cancer, CRCT2 is constitutively activated by SIKs inactivation and promotes the progression of NSCLC by binding to CREB to initiate transcription of downstream genes 11.